The Clinical/Statistical Core will provide the research projects with appropriate human clinical specimens and data from studies of vaccination or infection for influenza, pneumococcus, and varicella zoster virus. The Clinical/Statistical Core has three units that will support the research projects: the Hope Clinic Unit located at Emory U.;the Denver Clinic Unit located at the U of Colorado;and the Statistical Unit located at Emory U.
The specific aims of the Clinical/Statistical Core are:
Specific aim 1) To provide clinical study expertise and capacity to ensure the success of the U19 scientific agenda.
Specific aim 2) To provide statistical and data management expertise that ensures the success of the U19 scientific agenda.
Specific aim 3) To perform clinical studies with inactivated trivalent influenza vaccine (TIV) that will provide the clinical specimens and data necessary to accomplish the scientific aims of the research projects.
Specific aim 4) To perform clinical studies with 23-valent pneumococcal polysaccharide vaccine (PPV23) and in subjects with pneumococcal infections that will provide the clinical specimens and data necessary to accomplish the scientific aims of the projects.
Specific aim 5) To perform clinical studies with zoster vaccine (ZV) and with herpes zoster (HZ) patients that will provide the clinical specimens and data necessary to accomplish the scientific aims of projects 1 and 2.

Public Health Relevance

;Our recent work with the yellow fever vaccine demonstrates that systems biology approaches provide a new and unbiased way to protje the immune response to vaccination in humans, and discover molecular signatures that can predict vaccine induced immunity. The overarching goal of the present U19 application is to determine whether such an approach is generally applicable to different types of vaccines in the young and elderiy populations. This core will support this endeavor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI090023-03
Application #
8379613
Study Section
Special Emphasis Panel (ZAI1-QV-I)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
3
Fiscal Year
2012
Total Cost
$700,313
Indirect Cost
$178,603
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Lynn, David J; Pulendran, Bali (2018) The potential of the microbiota to influence vaccine responses. J Leukoc Biol 103:225-231
Yu, Tianwei (2018) Nonlinear variable selection with continuous outcome: a fully nonparametric incremental forward stagewise approach. Stat Anal Data Min 11:188-197
Levin, Myron J; Cai, Guang-Yun; Lee, Katherine S et al. (2018) Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine. J Infect Dis 217:1055-1059
Hagan, Thomas; Pulendran, Bali (2018) Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? From Data to Understanding through Systems Biology. Cold Spring Harb Perspect Biol 10:
Kang, Hyun Min; Subramaniam, Meena; Targ, Sasha et al. (2018) Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat Biotechnol 36:89-94
Lopez, Romain; Regier, Jeffrey; Cole, Michael B et al. (2018) Deep generative modeling for single-cell transcriptomics. Nat Methods 15:1053-1058
Levin, Myron J; Kroehl, Miranda E; Johnson, Michael J et al. (2018) Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest 128:4429-4440
Upadhyay, Amit A; Kauffman, Robert C; Wolabaugh, Amber N et al. (2018) BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data. Genome Med 10:20
Bowen, James R; Zimmerman, Matthew G; Suthar, Mehul S (2018) Taking the defensive: Immune control of Zika virus infection. Virus Res 254:21-26
Woodruff, Matthew Charles; Kim, Eui Ho; Luo, Wei et al. (2018) B Cell Competition for Restricted T Cell Help Suppresses Rare-Epitope Responses. Cell Rep 25:321-327.e3

Showing the most recent 10 out of 105 publications